NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MGP Ingredients, Inc. ("MGP Ingredients, Inc." or the "Company") (NASDAQ: MGPI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MGP Ingredients, Inc. investors who were adversely affected by alleged securities fraud between May 4, 2023 and October 30, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/mgp ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/pacira-biosciences-inc-lawsui ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ: NXT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nextracker investors who were adversely affected by alleged securities fraud between February 1, 2024 and August 1, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/nextracker-inc-lawsuit-submis ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by alleged securities fraud between November 2, 2023 and October 30, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/regeneron-ph ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Aehr Test Systems, Inc. ("Aehr" or the "Company") (NASDAQ: AEHR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aehr investors who were adversely affected by alleged securities fraud between January 9, 2024 and March 24, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/aehr-lawsuit-submission-form?prid ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. ("Kyverna Therapeutics, Inc." or the "Company") (NASDAQ: KYTX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and/or traceable to the Company's o ...

NEW YORKJan. 21, 2025Revance Therapeutics, Inc.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29, 2024 and December 6, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=123844&wire=4 RVNC investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telepho ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Five9, Inc. ("Five9, Inc." or the "Company") (NASDAQ: FIVN) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Five9, Inc. investors who were adversely affected by alleged securities fraud between June 4, 2024 and August 8, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/five9-inc-lawsuit-submission-form? ...

Shares of Intel (INTC 9.25%) were a massive disappointment in 2024. Multiple missteps culminated with the surprise retirement of CEO Pat Gelsinger late last year, and the company is now led by interim co-CEOs without a clear strategy. Investors are right to be skeptical of an Intel turnaround.While management could start to turn things around this year, there are multiple major risks that could further derail the stock.Everything is riding on Intel 18AIntel 18A is the fifth and final process node in Intel's ...

Oliver Rodzianko is an investment analyst specializing in the technology sector, grounded in timeless value principles. His expertise spans AI, semiconductors, software, and renewable energy, with a focus on companies that demonstrate resilient management and lasting competitive advantages. A trusted voice in financial analysis, Rodzianko’s insights are frequently highlighted as 'Must Reads' on Seeking Alpha, syndicated to Forbes via GuruFocus, and published on TipRanks.Rodzianko specializes in value tradin ...